Suppr超能文献

氨苄西林与舒巴坦联合用药对临床分离厌氧菌的作用

[The effect of a combination of ampicillin and sulbactam against clinical anaerobic isolates].

作者信息

Werner H, Heizmann W, Heilmann F

机构信息

Abteilung Medizinische Mikrobiologie, Hygiene-Institut der Universität, Tübingen.

出版信息

Arzneimittelforschung. 1988 Jul;38(7):866-8.

PMID:3207432
Abstract

Effect of a Combination of Ampicillin and Sulbactam on Clinical Isolates of Anaerobic Bacteria. The antimicrobial susceptibility of 182 recent clinical isolates of anaerobic bacteria to ampicillin alone, ampicillin plus 1 mg/l sulbactam, ampicillin plus 5 mg/l sulbactam, and cefoxitin was studied by means of agar dilution tests. The ampicillin-sulbactam combination (Unacid) was most effective against species of the Bacteroides fragilis group, the MIC90 of ampicillin plus 5 mg/l sulbactam for B. fragilis being less than or equal to 1 mg/l, compared to 256 mg/l of ampicillin, 4 mg/l of ampicillin plus 1 mg/l sulbactam, and 8 mg/l of cefoxitin. No significant difference between ampicillin alone and in combination with sulbactam was observed against gram-positive anaerobic rods or cocci.

摘要

氨苄西林与舒巴坦联合用药对厌氧菌临床分离株的影响。通过琼脂稀释试验研究了182株近期厌氧菌临床分离株对单独使用氨苄西林、氨苄西林加1mg/L舒巴坦、氨苄西林加5mg/L舒巴坦以及头孢西丁的抗菌敏感性。氨苄西林 - 舒巴坦联合制剂(优立新)对脆弱拟杆菌群最为有效,氨苄西林加5mg/L舒巴坦对脆弱拟杆菌的MIC90小于或等于1mg/L,相比之下,氨苄西林为256mg/L,氨苄西林加1mg/L舒巴坦为4mg/L,头孢西丁为8mg/L。对于革兰氏阳性厌氧杆菌或球菌,未观察到单独使用氨苄西林与联合舒巴坦之间存在显著差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验